Telehealth companies are mailing a Schedule III narcotic to tens of thousands of depressed patients, hailing it as the democratization of mental health. They call it access. I call it abandonment.
A sweeping review of 67 trials has cast doubt on the use of ketamine and similar NMDA receptor antagonists for chronic pain relief. While ketamine is frequently prescribed off-label for conditions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results